Annual ROE:
-881.26%-845.20%(-2343.87%)Summary
- As of today, AMRX annual return on equity is -881.26%, with the most recent change of -845.20% (-2343.87%) on December 31, 2024.
- During the last 3 years, AMRX annual ROE has fallen by -886.71% (-16269.91%).
- AMRX annual ROE is now -555.55% below its all-time high of 193.45%, reached on December 1, 2007.
Performance
AMRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-49.83%-3.92%(-8.54%)Summary
- As of today, AMRX quarterly return on equity is -49.83%, with the most recent change of -3.92% (-8.54%) on September 30, 2025.
- Over the past year, AMRX quarterly ROE has increased by +319.45% (+86.51%).
- AMRX quarterly ROE is now -116.45% below its all-time high of 302.92%, reached on December 1, 2006.
Performance
AMRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AMRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -2343.9% | +86.5% |
| 3Y3 Years | -10000.0% | +40.3% |
| 5Y5 Years | -807.6% | -1879.6% |
AMRX ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | >-9999.0% | at low | -154.6% | +86.5% |
| 5Y | 5-Year | -4619.3% | at low | -154.6% | +86.5% |
| All-Time | All-Time | -555.5% | at low | -116.5% | +98.5% |
AMRX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | -49.83%(-8.5%) |
| Jun 2025 | - | -45.91%(-38.7%) |
| Mar 2025 | - | -33.10%(-136.3%) |
| Dec 2024 | -881.26%(-2343.9%) | 91.24%(+124.7%) |
| Sep 2024 | - | -369.28%(-130.0%) |
| Jun 2024 | - | -160.53%(-55.1%) |
| Mar 2024 | - | -103.51%(-242.7%) |
| Dec 2023 | -36.06%(+58.1%) | -30.20%(-249.9%) |
| Sep 2023 | - | 20.15%(+241.5%) |
| Jun 2023 | - | 5.90%(+105.5%) |
| Mar 2023 | - | -107.45%(-20.1%) |
| Dec 2022 | -85.96%(-1677.2%) | -89.45%(-7.2%) |
| Sep 2022 | - | -83.47%(-10.1%) |
| Jun 2022 | - | -75.80%(>-9900.0%) |
| Mar 2022 | - | -0.21%(-104.0%) |
| Dec 2021 | 5.45%(-72.1%) | 5.24%(-40.9%) |
| Sep 2021 | - | 8.86%(+88.5%) |
| Jun 2021 | - | 4.70%(+146.4%) |
| Mar 2021 | - | -10.12%(-155.0%) |
| Dec 2020 | 19.50%(+120.1%) | 18.40%(+557.1%) |
| Sep 2020 | - | 2.80%(+103.9%) |
| Jun 2020 | - | -72.17%(-9.4%) |
| Mar 2020 | - | -65.98%(+30.3%) |
| Dec 2019 | -97.10%(-381.6%) | -94.66%(-27.2%) |
| Sep 2019 | - | -74.40%(-260.1%) |
| Jun 2019 | - | -20.66%(+17.0%) |
| Mar 2019 | - | -24.89%(-126.5%) |
| Dec 2018 | -20.16%(-1593.3%) | -10.99%(-29.9%) |
| Sep 2018 | - | -8.46%(+66.6%) |
| Jun 2018 | - | -25.36%(-3422.2%) |
| Mar 2018 | - | -0.72%(-118.2%) |
| Dec 2017 | 1.35%(+102.4%) | -0.33%(+99.3%) |
| Sep 2017 | - | -44.70%(+15.5%) |
| Jun 2017 | - | -52.89%(-5.1%) |
| Mar 2017 | - | -50.30%(-0.9%) |
| Dec 2016 | -55.98%(-1499.5%) | - |
| Dec 2016 | - | -49.87%(-183.0%) |
| Sep 2016 | - | -17.62%(-640.5%) |
| Jun 2016 | - | 3.26%(-5.8%) |
| Mar 2016 | - | 3.46%(-13.7%) |
| Dec 2015 | 4.00%(-40.8%) | 4.01%(+35.9%) |
| Sep 2015 | - | 2.95%(+247.1%) |
| Jun 2015 | - | 0.85%(-83.4%) |
| Mar 2015 | - | 5.11%(-23.7%) |
| Dec 2014 | 6.76%(-49.9%) | 6.70%(+18.6%) |
| Sep 2014 | - | 5.65%(+47.5%) |
| Jun 2014 | - | 3.83%(+1267.9%) |
| Mar 2014 | - | 0.28%(-97.8%) |
| Dec 2013 | 13.49%(+56.1%) | 12.88%(-15.4%) |
| Sep 2013 | - | 15.23%(-18.6%) |
| Jun 2013 | - | 18.71%(-13.4%) |
| Mar 2013 | - | 21.61%(+151.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | 8.64%(-26.6%) | 8.59%(-25.9%) |
| Sep 2012 | - | 11.60%(-0.2%) |
| Jun 2012 | - | 11.62%(+5.3%) |
| Mar 2012 | - | 11.03%(-6.3%) |
| Dec 2011 | 11.77%(-82.8%) | 11.77%(+11.9%) |
| Sep 2011 | - | 10.52%(-54.0%) |
| Jun 2011 | - | 22.88%(-20.9%) |
| Mar 2011 | - | 28.91%(-54.1%) |
| Dec 2010 | 68.56%(+161.8%) | 63.05%(-24.3%) |
| Sep 2010 | - | 83.30%(+7.7%) |
| Jun 2010 | - | 77.32%(-5.3%) |
| Mar 2010 | - | 81.62%(+191.8%) |
| Dec 2009 | 26.19%(+105.6%) | 27.97%(+120.1%) |
| Sep 2009 | - | 12.71%(+279.4%) |
| Jun 2009 | - | 3.35%(-73.5%) |
| Mar 2009 | - | 12.65%(+1.9%) |
| Dec 2008 | 12.74%(-93.4%) | 12.41%(+13.5%) |
| Sep 2008 | - | 10.93%(-76.6%) |
| Jun 2008 | - | 46.79%(-53.4%) |
| Mar 2008 | - | 100.36%(+6.9%) |
| Dec 2007 | 193.45%(+139.4%) | 93.86%(+102.9%) |
| Sep 2007 | - | -3290.44%(-55.4%) |
| Jun 2007 | - | -2116.88%(-1000.6%) |
| Mar 2007 | - | 235.06%(-22.4%) |
| Dec 2006 | -490.59%(-654.2%) | 302.92%(>+9900.0%) |
| Dec 2005 | -65.05%(-145.4%) | - |
| Sep 2004 | - | 1.50%(+134.4%) |
| Jun 2004 | - | -4.36%(+52.2%) |
| Mar 2004 | - | -9.12%(+64.8%) |
| Dec 2003 | -26.51%(+33.2%) | -25.89%(-4.0%) |
| Sep 2003 | - | -24.89%(+18.4%) |
| Jun 2003 | - | -30.51%(+23.4%) |
| Mar 2003 | - | -39.83%(+5.3%) |
| Dec 2002 | -39.68%(+6.0%) | -42.04%(+6.6%) |
| Sep 2002 | - | -45.02%(-1.4%) |
| Jun 2002 | - | -44.41%(-0.8%) |
| Mar 2002 | - | -44.06%(+6.8%) |
| Dec 2001 | -42.20%(+4.8%) | -47.29%(-2.9%) |
| Sep 2001 | - | -45.97%(+12.2%) |
| Jun 2001 | - | -52.35%(-2.9%) |
| Mar 2001 | - | -50.85%(+5.9%) |
| Dec 2000 | -44.32%(-39.3%) | -54.02%(-16.6%) |
| Sep 2000 | - | -46.31%(-55.5%) |
| Jun 2000 | - | -29.78%(-24.2%) |
| Mar 2000 | - | -23.98%(-39.7%) |
| Dec 1999 | -31.82%(+72.6%) | -17.17%(+70.1%) |
| Sep 1999 | - | -57.44%(+19.9%) |
| Jun 1999 | - | -71.72%(+15.0%) |
| Mar 1999 | - | -84.39%(+6.5%) |
| Dec 1998 | -116.10% | -90.28%(-51.9%) |
| Sep 1998 | - | -59.42%(-52.5%) |
| Jun 1998 | - | -38.97%(-164.0%) |
| Mar 1998 | - | -14.76% |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual return on equity?
- What is the all-time high annual ROE for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual ROE year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly ROE year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual return on equity?
The current annual ROE of AMRX is -881.26%
What is the all-time high annual ROE for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual return on equity is 193.45%
What is Amneal Pharmaceuticals, Inc. annual ROE year-on-year change?
Over the past year, AMRX annual return on equity has changed by -845.20% (-2343.87%)
What is Amneal Pharmaceuticals, Inc. quarterly return on equity?
The current quarterly ROE of AMRX is -49.83%
What is the all-time high quarterly ROE for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly return on equity is 302.92%
What is Amneal Pharmaceuticals, Inc. quarterly ROE year-on-year change?
Over the past year, AMRX quarterly return on equity has changed by +319.45% (+86.51%)